Alpha lipoic acid for diabetic sensory neuropathy

A recent review article suggested that a dose of 600 mg alpha lipoic acid (ALA) daily administered for up to 5 weeks could offer benefits in symptoms of diabetic sensory neuropathy without significant side effects. This review also notes that ALA is already approved for treatment of neuropathy in Germany. Furthermore, it seems obviously a better choice than the opioids often prescribed for diabetic neuropathy pain, as these induce addiction.

For more on alpha lipoic acid, see the NYBC entries:
Jarrow ALA sustained and Montiff ALA. NYBC also stocks Jarrow ALA plus Biotin; biotin is a B vitamin that has also been recommended for diabetes.

REFERENCE:

McIlduff CE, Rutkove SB, Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. Therapeutics and Clinical Risk Management. Sept. 2011 Volume 2011:7 Pages 377 – 385

Advertisements